SOL Bio
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $3.1M
Investors
- 6
About SOL Bio
Based in Seoul, South Korea, and founded by Se-Hwan Paek in 2020, SOL Bio Corp. develops exosome diagnosis platform technology that uses exosome, a substance that appears in the early-stages of cancer, to diagnose prostate cancer and early stage malignant melanoma with high accuracy of up to 95% or more. The company holds key domestic and foreign patents. The company provides technology for early diagnosis of cancer and manufactures ExoMAIN, a multi-cancer early detection test that uses exosome isolation kit to detect 13 major cancer types. SOL Bio Corp. plans to focus on early commercialization of diagnostic equipment that can simultaneously diagnose three major cancers, including prostate cancer and melanoma, by securing key production facilities and live ammunition for clinical trials with this investment attraction. At the same time, it is spurring global licensing to sell diagnostic technology to overseas medical device companies. The company is also planning to be listed on KOSDAQ.
Who invested in SOL Bio
6 investors across 3 rounds
See all investors in SOL Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SOL Bio
Who invested in SOL Bio?
SOL Bio has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SOL Bio raised?
SOL Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SOL Bio last raise money?
SOL Bio's most recent round on record is a Series A, in Jul 2021.
What does SOL Bio do?
Based in Seoul, South Korea, and founded by Se-Hwan Paek in 2020, SOL Bio Corp.
Where is SOL Bio headquartered?
SOL Bio is headquartered in Seoul, South Korea.
Which VCs invest in companies like SOL Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at SOL Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SOL Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.